Project Number AARG-NTF-22-926555 Agency/Funding Organization Alzheimer's Association Funding Year 2022 View Full Project Details for Selective mTOR inhibition to treat Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 6. Autophagy, Endocytosis and Membrane Trafficking c. Endosomal/Lysosomal Dysfunction Researcher and Organization Principal Investigator Arany, Zoltan Principal Investigator Arany, Zoltan Awardee Organization The Trustees of the University of Pennsylvania Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement AARG-NTF FY Overall Cost $149,885 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Alzheimer's Association
